Back to MNPR

CITADEL ADVISORS LLC → MNPR

CITADEL ADVISORS LLC MNPR Position History

Monopar Therapeutics Inc. • Healthcare

Quarters held
7
Latest value
$2.2M
Q3 2026
Peak value
$3.4M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$223K
Q4 2025$331K
Q1 2026$3.2M
Q2 2026$3.4M
Q2 2026$3.4M
Q3 2026$1.6M
Q3 2026$2.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2.2M27.4K——
Q3 2026$1.6M20.5K——
Q2 2026$3.4M37.0K——
Q2 2026$3.4M37.0K——
Q1 2026$3.2M58.4K——
Q4 2025$331K5.1K——
Q2 2025$223K6.2K——

Other funds holding MNPR

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B